Relay Therapeutics to Participate in Two Upcoming Investor Conferences
Relay Therapeutics (RLAY), a clinical-stage precision medicine company, has announced its participation in two major investor conferences in March 2025. The company will be featured in fireside chat sessions at:
• TD Cowen's 45th Annual Health Care Conference on March 5, 2025, at 1:50 p.m. ET
• Barclays 27th Annual Global Healthcare Conference on March 11, 2025, at 11:00 a.m. ET
Both sessions will be accessible via live webcast through Relay Therapeutics' website in the News & Events section. Archived recordings will remain available for 30 days after each event. The company, known for combining computational and experimental technologies in drug discovery, makes these presentations available at https://ir.relaytx.com/news-events/events-presentations.
Relay Therapeutics (RLAY), un'azienda di medicina di precisione in fase clinica, ha annunciato la sua partecipazione a due importanti conferenze per investitori a marzo 2025. L'azienda sarà presente in sessioni di chat informali presso:
• Il 45° Annual Health Care Conference di TD Cowen il 5 marzo 2025, alle 13:50 ET
• Il 27° Annual Global Healthcare Conference di Barclays l'11 marzo 2025, alle 11:00 ET
Entrambe le sessioni saranno accessibili tramite webcast dal vivo attraverso il sito web di Relay Therapeutics nella sezione News & Events. Le registrazioni archiviate rimarranno disponibili per 30 giorni dopo ciascun evento. L'azienda, nota per combinare tecnologie computazionali ed esperimentali nella scoperta di farmaci, rende queste presentazioni disponibili su https://ir.relaytx.com/news-events/events-presentations.
Relay Therapeutics (RLAY), una empresa de medicina de precisión en etapa clínica, ha anunciado su participación en dos importantes conferencias de inversores en marzo de 2025. La empresa estará presente en sesiones de charlas informales en:
• La 45ª Conferencia Anual de Atención Médica de TD Cowen el 5 de marzo de 2025, a la 1:50 p.m. ET
• La 27ª Conferencia Anual Global de Atención Médica de Barclays el 11 de marzo de 2025, a las 11:00 a.m. ET
Ambas sesiones estarán accesibles a través de una transmisión en vivo a través del sitio web de Relay Therapeutics en la sección de Noticias y Eventos. Las grabaciones archivadas estarán disponibles durante 30 días después de cada evento. La empresa, conocida por combinar tecnologías computacionales y experimentales en el descubrimiento de medicamentos, pone estas presentaciones a disposición en https://ir.relaytx.com/news-events/events-presentations.
릴레이 테라퓨틱스(RLAY), 임상 단계의 정밀 의학 회사,는 2025년 3월에 열리는 두 개의 주요 투자자 회의에 참여한다고 발표했습니다. 이 회사는 다음과 같은 비공식 대화 세션에 참여합니다:
• TD Cowen의 제45회 연례 건강 관리 회의는 2025년 3월 5일 오후 1시 50분 ET에 진행됩니다.
• 바클레이즈 제27회 연례 글로벌 건강 관리 회의는 2025년 3월 11일 오전 11시에 진행됩니다.
두 세션 모두 Relay Therapeutics의 웹사이트 뉴스 및 이벤트 섹션을 통해 실시간 웹캐스트로 접근할 수 있습니다. 각 이벤트 후 30일 동안 아카이브된 녹음이 제공될 예정입니다. 약물 발견에서 계산 기술과 실험 기술을 결합하는 것으로 알려진 이 회사는 https://ir.relaytx.com/news-events/events-presentations에서 이러한 발표를 제공합니다.
Relay Therapeutics (RLAY), une entreprise de médecine de précision en phase clinique, a annoncé sa participation à deux grandes conférences d'investisseurs en mars 2025. L'entreprise sera présente lors de sessions de discussions informelles à :
• La 45e Conférence Annuelle sur les Soins de Santé de TD Cowen le 5 mars 2025 à 13h50 ET
• La 27e Conférence Annuelle Mondiale sur les Soins de Santé de Barclays le 11 mars 2025 à 11h00 ET
Les deux sessions seront accessibles via un webinaire en direct sur le site de Relay Therapeutics dans la section Actualités et Événements. Les enregistrements archivés resteront disponibles pendant 30 jours après chaque événement. L'entreprise, connue pour sa combinaison de technologies computationnelles et expérimentales dans la découverte de médicaments, met ces présentations à disposition sur https://ir.relaytx.com/news-events/events-presentations.
Relay Therapeutics (RLAY), ein Unternehmen für Präzisionsmedizin in der klinischen Phase, hat seine Teilnahme an zwei wichtigen Investorenkonferenzen im März 2025 bekannt gegeben. Das Unternehmen wird in informellen Gesprächsrunden vertreten sein bei:
• Der 45. jährlichen Gesundheitskonferenz von TD Cowen am 5. März 2025 um 13:50 Uhr ET
• Der 27. jährlichen globalen Gesundheitskonferenz von Barclays am 11. März 2025 um 11:00 Uhr ET
Beide Sitzungen sind über einen Live-Webcast auf der Website von Relay Therapeutics im Bereich Nachrichten & Veranstaltungen zugänglich. Archivierte Aufzeichnungen sind 30 Tage nach jeder Veranstaltung verfügbar. Das Unternehmen, das bekannt ist für die Kombination von rechnergestützten und experimentellen Technologien in der Arzneimittelentdeckung, stellt diese Präsentationen unter https://ir.relaytx.com/news-events/events-presentations zur Verfügung.
- None.
- None.
CAMBRIDGE, Mass., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, today announced that management will participate in two upcoming fireside chats:
- TD Cowen’s 45th Annual Health Care Conference on Wednesday, March 5, 2025 at 1:50 p.m. ET
- Barclays 27th Annual Global Healthcare Conference on Tuesday, March 11, 2025 at 11:00 a.m. ET
The fireside chats will be webcast live and may be accessed through Relay Therapeutics’ website under Events in the News & Events section through the following link: https://ir.relaytx.com/news-events/events-presentations. An archived replay of the webcast will be available for up to 30 days following the event.
About Relay Therapeutics
Relay Therapeutics (Nasdaq: RLAY) is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. As the first of a new breed of biotech created at the intersection of complementary techniques and technologies, Relay Therapeutics aims to push the boundaries of what’s possible in drug discovery. Its Dynamo® platform integrates an array of leading-edge computational and experimental approaches designed to drug protein targets that have previously been intractable or inadequately addressed. Relay Therapeutics’ initial focus is on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. For more information, please visit www.relaytx.com or follow us on Twitter.
Contact:
Pete Rahmer
prahmer@relaytx.com
Media:
Dan Budwick
1AB
973-271-6085
dan@1abmedia.com
FAQ
When is Relay Therapeutics (RLAY) presenting at TD Cowen's Healthcare Conference in 2025?
What time is RLAY's presentation at the Barclays Healthcare Conference in March 2025?
How long will the RLAY conference webcasts be available for replay?
Where can investors access Relay Therapeutics' conference presentations?
